Page last updated: 2024-08-23

silybin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

silybin has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (5.88)	29.6817
2010's	16 (94.12)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Althagafy, HS; Croatt, MP; Graf, TN; Gufford, BT; Oberlies, NH; Paine, MF; Polyak, SJ; Sy-Cordero, AA; Wagoner, J	1
Anagnostopoulos, A; Böni, J; Braun, DL; Durisch, N; Eberhard, N; Fehr, J; Ledergerber, B; Metzner, KJ; Rauch, A; Weber, R	1
Canini, L; Conway, JM; Cotler, SJ; Crespo, G; D'Amato, M; Dahari, H; DebRoy, S; Ferenci, P; Forns, X; Mariño, Z; Navasa, M; Perelson, AS	1
Ashkenazi, YJ; Cotler, SJ; D'Amato, M; Dahari, H; Gafanovich, I; Goldin, E; Lurie, Y; Pohl, RT; Shteingart, S; Tichler, T; Weiss, G	1
Guedj, J; Nguyen, TH	1
Meissner, EG	1
Khan, H; Murad, S; Neyts, J; Paeshuyse, J	1
Akamatsu, S; Canini, L; Chayama, K; Dahari, H; DebRoy, S; Hayes, CN; Hiraga, N; Imamura, M; Perelson, AS; Persiani, S; Pohl, RT; Tateno, C; Uprichard, SL	1
Angelico, R; Ceglie, A; Mangia, A; Ripoli, M; Sacco, P	1
Conti, P; De Tullio, D; Falasca, K; Mancino, P; Pizzigallo, E; Ucciferri, C; Vecchiet, J; Vitacolonna, E	1
Bahra, M; Berg, T; Biermer, M; Boas-Knoop, S; Eurich, D; Neuhaus, P; Neuhaus, R; Neumann, U	1
Ciesek, S; Wedemeyer, H	1
Dahari, H; Ferenci, P; Guedj, J; Perelson, AS; Pohl, RT	1
Dahari, H; Ferenci, P; Oberlies, NH; Pawlotsky, JM; Pécheur, EI; Polyak, SJ	1
Brambilla, N; Costa, J; Crespo, G; D'Amato, M; Forns, X; Giacovelli, G; Mariño, Z; Navasa, M; Rovati, L	1
Chatterjee, A; Perelson, AS; Smith, PF	1
Beinhardt, S; Ferenci, P	1

Reviews

3 review(s) available for silybin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Article	Year
Immunosuppression, liver injury and post-transplant HCV recurrence. Journal of viral hepatitis, 2012, Volume: 19, Issue:1 Topics: Antibodies, Neutralizing; Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Interferon-alpha; Liver; Liver Transplantation; Secondary Prevention; Silybin; Silymarin	2012
Silymarin for HCV infection. Antiviral therapy, 2013, Volume: 18, Issue:2 Topics: Animals; Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Silybin; Silymarin	2013
Hepatitis C viral kinetics: the past, present, and future. Clinics in liver disease, 2013, Volume: 17, Issue:1 Topics: Antiviral Agents; Carbamates; Deoxycytidine; Hepacivirus; Hepatitis C; Humans; Imidazoles; Models, Biological; Oligopeptides; Protease Inhibitors; Pyrrolidines; Silybin; Silymarin; Valine	2013

Trials

1 trial(s) available for silybin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Article	Year
Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period. Journal of hepatology, 2013, Volume: 58, Issue:3 Topics: Adult; Aged; Antiviral Agents; Double-Blind Method; Female; Hepatitis C; Humans; Injections, Intravenous; Liver Transplantation; Male; Middle Aged; Prospective Studies; RNA, Viral; Silybin; Silymarin; Viral Load	2013

Article

Year

Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period.

Journal of hepatology, 2013, Volume: 58, Issue:3

Topics: Adult; Aged; Antiviral Agents; Double-Blind Method; Female; Hepatitis C; Humans; Injections, Intravenous; Liver Transplantation; Male; Middle Aged; Prospective Studies; RNA, Viral; Silybin; Silymarin; Viral Load

2013

Other Studies

13 other study(ies) available for silybin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Article	Year
Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle. Bioorganic & medicinal chemistry, 2013, Jul-01, Volume: 21, Issue:13 Topics: Antiviral Agents; Aryl Hydrocarbon Hydroxylases; Cell Line; Cell Survival; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Drug Interactions; Glucuronosyltransferase; Hepacivirus; Hepatitis C; Humans; Methylation; Microsomes; Silybum marianum; Silymarin	2013
Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients. HIV medicine, 2014, Volume: 15, Issue:10 Topics: Adult; Anti-Retroviral Agents; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Pilot Projects; Protease Inhibitors; RNA, Viral; Silybin; Silymarin	2014
Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy. Antiviral therapy, 2015, Volume: 20, Issue:2 Topics: Adult; Age Factors; Aged; Antioxidants; Biological Availability; Cell Death; Computer Simulation; Female; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Models, Statistical; Severity of Illness Index; Silybin; Silymarin; Viral Load	2015
Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:2 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Injections, Intravenous; Kinetics; Models, Biological; Precision Medicine; Ribavirin; RNA, Viral; Silybin; Silymarin; Time Factors	2015
Can we use viral kinetic models to individualize treatment? Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:2 Topics: Hepacivirus; Hepatitis C; Humans; Models, Biological; Precision Medicine; RNA, Viral; Silybin; Silymarin	2015
Continued value in understanding viral kinetic decline during interferon-free therapy for HCV. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:2 Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Recurrence; RNA, Viral; Silybin; Silymarin; Virus Replication	2015
Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countries. Antiviral research, 2016, Volume: 125 Topics: Antiviral Agents; Catechin; Food Additives; Genotype; Hepacivirus; Hepatitis C; Humans; Nitro Compounds; Prevalence; Silybin; Silymarin; Thiazoles; Virus Replication	2016
Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy. Journal of viral hepatitis, 2016, Volume: 23, Issue:9 Topics: Administration, Intravenous; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Gene Expression Profiling; Hepacivirus; Hepatitis C; Humans; Liver; Mice, SCID; Microarray Analysis; Models, Theoretical; RNA, Viral; Sequence Analysis, DNA; Serum Albumin; Silybin; Silymarin; Treatment Outcome; Viral Load	2016
Phytoliposome-Based Silibinin Delivery System as a Promising Strategy to Prevent Hepatitis C Virus Infection. Journal of biomedical nanotechnology, 2016, Volume: 12, Issue:4 Topics: Animals; Antioxidants; Antiviral Agents; Cell Survival; Diffusion; Hepacivirus; Hepatitis C; Humans; Liposomes; Nanocapsules; Plant Extracts; Silybin; Silymarin	2016
Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection. Journal of medical virology, 2008, Volume: 80, Issue:11 Topics: Adult; Aged; Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Cytokines; Female; Hepatitis C; Humans; Liver Function Tests; Male; Middle Aged; Silybin; Silymarin; Treatment Outcome; Viral Load; Vitamin E	2008
Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011, Volume: 9, Issue:1 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Infusions, Intravenous; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Silybin; Silymarin; Time Factors; Treatment Failure; Viral Load	2011
Understanding silibinin's modes of action against HCV using viral kinetic modeling. Journal of hepatology, 2012, Volume: 56, Issue:5 Topics: Adult; Aged; Antiviral Agents; Dose-Response Relationship, Drug; Genotype; Hepacivirus; Hepatitis C; Humans; Middle Aged; Models, Theoretical; RNA, Viral; Silybin; Silymarin; Treatment Outcome; Viral Load; Virus Replication	2012
Silibinin: an old drug in the high tech era of liver transplantation. Journal of hepatology, 2013, Volume: 58, Issue:3 Topics: Antiviral Agents; Female; Hepacivirus; Hepatitis C; Humans; Liver Transplantation; Male; Silybin; Silymarin	2013